Skip to content
Austin Top 50
Author:
Bolt Biotherapeutics, Inc.
Bolt Biotherapeutics Announces Acquisition of Prana Therapies and $120 Million Concurrent Private Placement to Advance PRA-216 in Multiple High-Value Inflammatory Indications
October 23, 2026
Bolt Biotherapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
August 11, 2026
Bolt Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
May 13, 2026